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SUMMARY
How the long non-coding RNA (lncRNA) genome in recombinant protein producing Chinese hamster
ovary (CHO) cell lines relates to phenotype is not well described. We therefore defined the CHO cell
lncRNA transcriptome from cells grown in controlled miniature bioreactors under fed-batch condi-
tions using RNA-Seq to identify lncRNAs and how the expression of these changes throughout growth
and between IgGproducers.We identify lncRNAs includingAdapt15, linked to ER stress,GAS5, linked
to mTOR signaling/growth arrest, and PVT1, linked to Myc expression, which are differentially
regulated during fed-batch culture and whose expression correlates to productivity and growth.
Changes in (non)-coding RNA expression between the seed train and the equivalent day of fed-batch
culture are also reported and comparedwith existing datasets. Collectively, we present a comprehen-
sive lncRNA CHO cell profiling and identify targets for engineering growth and productivity charac-
teristics of CHO cells.
INTRODUCTION
Many recombinant protein biopharmaceuticals are expressed inmammalian expression systems due to the
ability of such systems to correctly fold, assemble, and undertake ‘‘human-like’’ post-translational modifi-
cations and secrete the target protein out of the cell (Walsh, 2010). Of mammalian cell expression systems
one predominates, with more than 60% of mammalian made biotherapeutic proteins produced from
cultured Chinese hamster ovary (CHO) cells (Kunert and Reinhart, 2016; Leu et al., 2004; Mead et al.,
2015; Povey et al., 2014; Walsh, 2010). Fed-batch culture is currently the most common bioprocess used
for the industrial production of proteins in CHO cells, generating increased cell concentrations (and
hence biomass) and sustained culture viability compared with batch culture, ultimately resulting in higher
productivity and final product yields (Durocher and Butler, 2009; Pan et al., 2017; Wong et al., 2006). The
introduction of small-scale parallel bioreactors allowing automated sampling and continuous control of
fundamental culture parameters, including pH, stirring, and temperature has enhanced the ability to screen
a wider range of culture parameters and cell lines, leading to improved upstream development timelines
and experimental throughput (Bareither and Pollard, 2011).
The ambr15 cell culture system (Sartorius Stedim Biotech) has been shown to give similar cell growth and
productivity data to those achieved in larger-scale stirred bioreactors, enabling more accurate predictions
compared with shake flasks on the behavior of a cell line at larger scale (Alsayyari et al., 2018; Janakiraman
et al., 2015; Nienow et al., 2013; Rouiller et al., 2016). This capacity to conduct small-scale experiments
under controlled conditions, of a highly predictive nature at larger scale, allows the investigation of the
behavior of different cell lines under alternative feeding regimes to determine how each respond. Indeed,
recent reports state that the ambr15 small-scale automated and controlled bioreactor system provides an
excellent scale-down model to facilitate studies on multiple cell lines under controlled industrially relevant
conditions to identify robust targets linked to productivity for cell engineering and material and data for
future regulatory submissions (Sandner et al., 2019).
Despite advancements in the ability of CHO cells to reach higher cell concentrations and generate
increasing amounts of target biotherapeutic proteins, particularly monoclonal antibodies (mAbs), there re-
mains a desire to further understand the limitations upon CHO cell phenotypes and to engineer cells for the
production of more difficult-to-express products (Godfrey et al., 2017; Josse´ et al., 2018; Mead et al., 2009).
One approach that has been applied toward improving our understanding of the limitations on CHO cell
growth and recombinant protein production is the field of transcriptomics (Tamosaitis and Smales, 2018).
Transcriptomic studies in particular could benefit from generating material from controlled miniature
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bioreactors that predict behavior at larger scale, as an issue of such previous studies is reproducibility and
robustness across different transcriptomic datasets, given the high heterogeneity of CHO cell lines and
their intrinsic genetic instability (Chen et al., 2017; Wurm, 2013; Wurm and Wurm, 2017). The availability
of CHO cell and Chinese hamster genome sequences (Lewis et al., 2013; Xu et al., 2011) has greatly enabled
omics-based studies (Faustrup Kildegaard et al., 2013), and since there has been an increasing number of
publicly available databases for different CHO cell lines. However, the focus of these studies has been on
either coding genes or microRNAs (miRNAs), with few studies investigating other classes of RNAs and their
impact on CHO cell behavior (Singh et al., 2018; Tamosaitis and Smales, 2018).
Here we investigate the long non-coding transcriptome in CHO cells during fed-batch culture under
controlled bioreactor conditions. Since the unraveling of multiple organisms genomes, particularly eukaryotic
genomes, associatedwith the development of high-throughput sequencing technologies, new classes of non-
coding RNA have been identified (Djebali et al., 2012). Among these, a class of transcripts known as long non-
coding RNAs (lncRNAs) was identified. lncRNAs are defined as transcripts longer than 200 nucleotides that
lack a significant open reading frame (ORF), are usually transcribed by RNA polymerase II, and are spliced
with, or without, 30 polyadenylation (Kashi et al., 2016; Kung et al., 2013;Wilusz, 2016). In the nucleus, cis-acting
lncRNAs regulate the chromatin state and transcription of nearby genes, whereas trans-acting lncRNAs can
recruit RNA-binding proteins to form chromatin-modifying complexes and modulate splicing or organize
functional nuclear domains (Kopp and Mendell, 2018). When transported to the cytoplasm, lncRNAs act at
a post-transcriptional level by promoting specific mRNA translation or turnover and by competitively binding
microRNAs (miRNAs), attenuating the repression of target genes (Geisler and Coller, 2013). The wide range of
processes involving lncRNAs suggests that some of these may be potential cell engineering targets to rewire
CHO cell phenotypes for enhanced cell growth and/or recombinant protein production and quality without
placing a translational burden on the cell compared with overexpression of coding genes. However, the
majority of our knowledge around lncRNAs comes from studies in model organisms related to disease and
development (Perry and Ulitsky, 2016; Schmitt and Chang, 2016) with lncRNAs poorly annotated in the
CHO cell genome and little known about their role in defining CHO cell phenotypes.
A recent report described the lncRNA landscape in CHO cells, showing regulated expression of thousands
of lncRNAs under batch and fed-batch conditions over time (Vito and Smales, 2018). Others have demon-
strated the potential power of lncRNA cell engineering to manipulate the cells’ ability to produce target
recombinant proteins with the engineering of a class of lncRNAs named SINEUPs enhancing the translation
of target-specific mRNAs in various mammalian cell factories (Patrucco et al., 2015; Zucchelli et al., 2016).
However, the limited number of studies and poor annotation of non-coding regions in the Chinese hamster
genome means that transcriptomics across multiple cell lines associated with phenotypes of interest under
industrially relevant and controlled conditions is required to identify lncRNAs whose manipulation may
enhance mammalian cell factories’ ability to generate secreted target products (Vishwanathan et al.,
2014). Here we present a comprehensive coding and non-coding, particularly lncRNA, transcriptome anal-
ysis using RNA-Seq of five IgG1 producing CHO cell lines and one stable pool harboring the plasmid
cassette without genes encoding for the IgG1, cultivated under fed-batch conditions in an ambr15 sys-
tem to unveil lncRNA targets for cell engineering. The RNA-Seq datasets and analyses are made openly
available to the community to promote further studies and comparisons, providing a detailed CHO cell
lncRNA transcriptomic resource with a focus on particular genes and pathways.
RESULTS AND DISCUSSION
Following our previous landscape of lncRNA expression in CHO using microarray (Vito and Smales, 2018),
we set out to provide an analysis of the lncRNA transcriptome using RNA-Seq in CHO cells producing
three different model IgG1 monoclonal antibodies during fed-batch culture, defining those lncRNAs ex-
pressed in CHO cells and the flux of these during culture and between cell lines. To do this, we undertook
RNA-Seq analysis on a panel of IgG-expressing CHO DHFR- cell lines (these cell lines being generated
from a modified dihydrofolate reductase-deficient (DHFR-) CHO DG44 host cell line, (Urlaub et al.,
1983)), sampling throughout fed-batch cultures in an ambr15 microbioreactor system generating profiles
of the flux of coding RNAs and lncRNAs.
Analysis of Fed-Batch Culture Samples
The DAVI dataset included the 3068, 3080 and 3077 IgG1-producing cell lines and the null pool 3478,
cultured for 12 days (Table 1). These cell lines maintained culture viabilities >80% throughout the
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12 days of fed-batch culture, reaching a peak in viable cell concentration (VCD) at 14.48 x 106 viable
cells/mL for cell line 3077, whereas 3080 had the lowest VCD throughout culture (Figure 1A). 3080 reached
the highest titer at 1.80 g/L and productivity (Qp) at 31.71 pg/cell/day (3080) associated with the highest
amount of lactate accumulated during the first few days of culture, with a peak concentration of 2.2 g/L
(Figures 1B–1D). The glutamate, glutamine, and ammonia profiles were similar across all cell lines (Fig-
ure S1). Overall, the highest productivity was associated with the highest lactate accumulation causing
the lowest VCDs for 3080, whereas the rest of the producers did not show this association compared
with the null pool.
The JCE dataset included the 3068, 3080, and 4384 IgG1-producing cell lines and the 3936 IgG1-producing
pool, cultured for 14 days (Table 1). Once again, 3080 was the cell line showing the lowest VCDs and the high-
est accumulation of lactate at approximately 3.5 g/L at Day 5, whereas culture viability profiles were broadly
comparable across cell lines, being within the range of 60%–80% on the last day of culture (Figures 1E and 1G).
When the Qp was calculated, the 3068 and 3080 cell lines had the highest Qps at 35.20 and 35.81 pg/cell/day
respectively, whereas 3936 had the lowest Qp, as would be expected from a pool of clones (Figure 1H). The
glutamate, glutamine, and ammonia profiles were again broadly similar across cell lines (Figure S1). In
summary, 3080 repeated the trend observed in the DAVI dataset of lowest VCD associated with highest
productivity and highest accumulation of lactate, but 3068 followed closely in productivity.
RNA Sequencing of ambr15-Generated Samples and Subsequent Analysis of the Data: The
DAVI Experiment
As described in the methods section, samples for RNA-Seq were collected in duplicate at Day 4 and Day 12
of fed-batch culture from the ambr15 reactors. Gene counts were calculated using featureCounts, then
the differential expression analysis was undertaken with the R/Bioconductor package DESeq2 (Love
et al., 2014). Clustering analysis of the RNA-Seq data revealed that the samples showed a consistent hier-
archical clustering for the biological replicates and an evident separation between the two time points
based on gene expression (Figures 2A and 2B). This separation was confirmed by principal component
analysis (PCA); however, an additional layer of clustering emerged among the producers upon PCA with
a difference in Qp, clearly showing clusters formed of 3077 and 3068 (23.05 and 26.53 pg/cell/day) that
were distanced from cell line 3080 (31.71 pg/cell/day) and the null-pool 3478 (Figure 2C). Overall, this pre-
liminary cluster analysis based on total gene expression suggests a grouping of cell lines directly related to
differences in Qp more than maximum viable cell concentrations for this dataset.
Differential transcript expression (DE) analysis was then conducted using the DESeq2 R software package,
setting a fold-change (FC) threshold of 1.50. DE genes were considered significant if the adjusted p value
for this FC threshold calculated using the Benjamini-Hochberg method was below 0.10. As expected, the
longest distances observed in clustering and PCA analyses corresponded to a higher number of DE genes
Cell Line Clonality Peak VCD [Viable Cells/Day] Yield [g/L] Qp [pg/Cell/Day]
DAVI Experiment
3478 Pool 10.66 x 106 – –
3068 Clone 9.38 x 106 1.48 26.53
3077 Clone 14.48 x 106 1.96 23.05
3080 Clone 8.56 x 106 1.80 31.71
JCE Experiment
3068 Clone 8.52 x 106 2.64 35.20
3080 Clone 6.94 x 106 2.25 35.81
4384 Clone 11.01 x 106 2.43 23.39
3936 Pool 10.67 x 106 1.23 13.25
Table 1. Cell Line Detail/Name, Clonality, Peak Viable Cell Number (VCD), the IgG Yield at Day 12 for DAVI and Day
14 for JCE and the Cell Specific Productivity for the Model IgG1-Expressing Cells Used in the Experiments
Described in the Study
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overall (Figure 3). Consequently, samples collected at Day 12 showed the highest variability when
compared between them or against Day 4 samples, with the exception of 3077 vs 3068, which indeed clus-
tered together in PCA (Figure 2). Within the identified DE genes, lncRNAs made up 10–30% of the total
number identified (Figure 3). A representative group of differentially expressed coding and non-coding
RNAs were then selected (see section on identification of differentially expressed lncRNAs as potential
cell engineering targets) for RT-qPCR validation, resulting in a positive correlation between the fold-
changes measured by RNA-Seq and by RT-qPCR (Data S2).
RNA Sequencing of ambr15-Generated Samples and Subsequent Analysis of the Data: The
JCE Experiment
In the JCE experiment, samples for RNA-Seq were collected in triplicate from the seed train (ST) flasks
and at Day 4 and Day 7 of fed-batch culture. The samples showed a hierarchical clustering for each biolog-
ical triplicate, but the separation into groups as observed in the DAVI experiment was not as evident
(Figures 2E and 2F). PCA revealed a similar pattern where only a clear separated cluster composed of
the 4384 cell line samples was distinguishable from the other samples (Figure 2G). The 4384 clones showed
the highest VCD throughout culture (Figure 1E) and the observed distance in the PCA clustering reflected
in the high number of DE genes identified when comparing this cell line against the others, especially on
Day 4 (Figure 3). Although less predominant, the presence of sub-clusters grouped by time point with the
same general trend can be observed among the rest of the samples (Figure 2G). We then compared the
gene expression profiles of the seed-train cultures that were used to start the fed-batch process, obtained
from cells during logarithmic growth phase, with the Day 4 gene expression profiles of the fed-batch cul-
ture experiments. Although cells from the seed train and fed-batch Day 4 ambr15 bioreactor might be
expected to be in a similar growth andmetabolic state, we found significant differences in gene expression
numbers at this early stage of culture, particularly for 3068 where the number of DE genes identified was
761 (Figure 3). Overall, the hierarchical clustering, PCA, and DE analysis suggest the 4384 cell line has a
distinct transcriptional landscape, whereas 3068, 3936, and 3080 have much closer gene expression pro-
files. Further, the seed train samples of each cell line show, to varying degrees, different gene expression
profiles than that of cells taken from the fed-batch cultures in an equivalent growth phase.
Investigating Pathway Enrichment in DE Genes
KEGG pathway functional enrichment of the RNA-Seq datasets based on statistically significant differen-
tially expressed genes showed two distinct patterns across the datasets. Firstly, a major theme of
Figure 1. Parameters Measured and Monitored during Fed-Batch Culture of Model IgG1 Expressing CHO Cell Clones and a Null Pool
The parameters measured andmonitored during fed-batch culture of model IgG1-expressing CHO cell clones and a null pool for the DAVI dataset (A–D) and
the JCE dataset (E–H).
(A and E) Viable cell density (VCD) and viability over time.
(B and F) Yield of IgG1 antibody over time.
(C and G) Lactate concentration over time.
(D and H) Productivity (Qp) for each cell line.
Data are represented as mean G SEM.
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enrichment in the DAVI dataset was in the Replication and Repair area, where DE genes were found to be
enriched in DNA replication, base excision repair, nucleotide excision repair, mismatch repair, homolo-
gous recombination, and Fanconi anemia pathways among the 3077, 3068, and 3478 cell lines when
comparing Day 12 versus Day 4 expression profiles within the same cell line (Figure 4). Interestingly, the
only cell line in the DAVI dataset in which none of these pathways was enriched was the 3080 cell line. In
the DAVI dataset this was the cell line with highest Qp associated with lowest VCD and a clear distinction
from the others when the RNA-Seq data were analyzed by PCA. On the other hand, comparing the different
cell lines to each other among Day 4 or Day 12 did not reveal any enriched pathways related to genome
maintenance (Figure S2). Thus, within a given cell line changes in genome maintenance pathways were
observed over time between days 4 and 12 of culture; however, when same time points of different cell lines
were compared this was not observed.
We then applied the same enrichment analysis to the JCE dataset, and surprisingly none of the pathways
involved in genome maintenance were enriched within the DE genes between Day 4 and Day 7 (Figure S3).
An analysis of the seed train versus fed-batch DE genes for the 3080 and 3068 cell lines revealed enrichment
of the DNA replication pathway and for the seed train versus 4384 cell line enrichment of the nucleotide
excision repair, mismatch repair, and DNA replication pathways (Figure S4). The pathway enrichment anal-
ysis also consistently revealed the enrichment of the PI3K-Akt signaling pathway, focal adhesion, and
ECM-receptor interaction pathways in the DE genes across both the DAVI and JCE datasets. Overall,
the enrichment suggests a prominent regulation of genome maintenance mechanisms is conserved across
different cell lines at the passage from seed train to fed-batch culture and toward the end of culture,
whereas the most differentially regulated pathways at the same stage in culture for the same cell lines
are the PI3K-Akt signaling, focal adhesion, and ECM-receptor pathways.
Focusing on individual genes involved in the replication and repair domain, we identified exonuclease 1
(Exo1), Rad51, essential meiotic structure-specific endonuclease 1 (Eme1) and FA complementation
group B (Fancb) in common among the top 30 most differentially expressed genes in both the DAVI
and JCE datasets (Figure S5). These genes are involved in a wide range of genome repair mechanisms
from mismatch repair to homologous recombination and DNA double-strand break repair, suggesting a
Figure 2. Clustering Analysis and PCA of Samples and Genes
From left to right the clustering based on the distance between each sample (A and D), the clustering based on the top 30 most differentially expressed
genes expression (B and E), and the PCA of normalized gene expression for the first two principal components (C and F). Panels (A–C) show the DAVI dataset.
The type indicates whether the samples are from the non-producing pool (Null) or from producing clones (Producer), whereas the condition groups replicate
of the same cell line and time point. Panels (D–F) show the JCE dataset. The type indicates whether the samples are from fed-batch culture (FB) or from the
seed-train (ST), whereas the condition groups replicate of same cell line and time point.
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co-regulation of multiple facets of genome maintenance and the importance of high fidelity in these path-
ways to maintain cell integrity, viability, and growth as culture progresses.
Mapping of Long Non-coding RNA Expression During Fed-batch Culture
As outlined in the introduction section, a key aspect of this study was to generate a detailed description
of lncRNA expression under controlled bioreactor conditions in different IgG-producing CHO cells
and to identify lncRNAs whose manipulation may enhance the CHO cell factory’s ability to generate
secreted target products. In order to identify non-coding RNAs, all the significant differentially expressed
non-coding genes were filtered based on NCBI annotation and are shown as a percentage of the
total number of differentially expressed genes for each comparison in Figure 3 and in Table S1. The
DAVI dataset showed a higher percentage of ncRNAs on average (22.2%) compared with JCE (14.0%)
as a percentage of the total DE RNAs identified, most likely due to the higher coverage in the
sequencing data for the DAVI dataset. The complete RNA-Seq dataset is provided reporting those
lncRNAs identified as being expressed in CHO cells and hence providing a reference for the community
to investigate individual lncRNAs in CHO cells (see GEO accession number GEO: GSE140671 and
Data S1).
Figure 3. Depiction of the Number of Differentially Expressed Genes between Different Sample Comparisons
The number of differentially expressed genes with an FCR 1.5, adj p value < 0.1 (DE genes were considered significant if
the adjusted p value for this fold chnage (FC) threshold calculated using the Benjamini-Hochberg method was below
0.10). In blue is shown the DAVI dataset and in red is shown the JCE dataset while the size of the dot indicates the % of
lncRNAs for each comparison. For each comparison, the exact number of genes is indicated on the right.
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Identification of Differentially Expressed lncRNAs as Potential Cell Engineering Targets
We then looked to filter and refine the list of DE lncRNAs by counting the occurrence of each transcript in
all the DE comparisons, assessing sequence conservation across mammalian species through the discon-
tiguous megablast algorithm and secondary structure prediction based on the RFAM database (Kalvari
et al., 2018). Each lncRNA identified via this strategy was then experimentally validated by RT-qPCR to
confirm the differential expression between conditions in CHO cells (Data S2). The first lncRNA identified
via this approach was Adapt15. LncRNA Adapt15 (also known as growth-arrested DNA-damage inducible
gene 7, Gadd7) was discovered in hamster cells, with orthologs identified in the closely related
C. longicaudatus and sequence conservation across rodents (Crawford et al., 1996). More recently,
Adapt15 has been linked to oxidative lipotoxicity, with knockdown alleviating ER stress and cell death
(Brookheart et al., 2009). In the DAVI dataset at Day 12, Adapt15 was consistently upregulated in the
3077, 3068, and 3080 cell lines compared with the null pool 3478 (Table 2). Interestingly, the lowest FC
was measured in 3080, the clone with the highest Qp, suggesting Adapt15 expression could be a bottle-
neck for protein production when the ER is put under stress. In addition, Adapt15 is a known contributor
to DNA damage, and 3080 was the only clone not showing DNA-damage-related pathway enrichment in
the KEGG analysis previously described (Hollander et al., 1996). Clones with naturally lower levels of
Adapt15 could be able to escape these detrimental effects on productivity and genome stability.
Conversely, within the JCE dataset, which is focused only on producers and comparison of earlier stages
of culture, there was no significant DE of Adapt15 identified, suggesting DE expression of this transcript
is observed in producer cell lines compared with a non-producing control later in fed-batch culture.
A second lncRNA that showed significant DE was growth-arrest-specific transcript 5 (GAS5), a multiple
small nucleolar RNA (snoRNA) host gene (Smith and Steitz, 1998) with a short ORF and a well-known tumor
suppressor lncRNA in human cancer biology (Ma et al., 2016). As a result of cell growth arrest and mTOR
pathway activity repression, translation of the GAS5 short ORF is blocked and the transcript accumulates,
escaping the nonsense-mediated decay (NMD) pathway that depends on active translation (Ma et al., 2016;
Tani et al., 2013). We identified the uncharacterized gene LOC103158913 as a ortholog of mouse GAS5
in CHO using BLAST and RFAM predictions (Table 2). We then investigated its correlation with mTOR
expression by integrating the JCE and DAVI measurements for the 3068 and 3080 producers to obtain
four time points (Figure 5). We found a stable ratio between mTOR and GAS5 until Day 12, when mTOR
expression became predominant, especially in the highest producer 3080. In addition, GAS5 was upregu-
lated at Day 12 in 3068 compared with the null pool and not in the 3080, whereas mTOR was never
Figure 4. Enriched KEGG Pathways Based on Differentially Expressed Genes
Enriched KEGG pathways based on differentially expressed genes for each comparison among the same cell line at Day 12 against Day 4 in the DAVI dataset.
Each dot represents a pathway, with color shade representing the p value, size proportional to the overlap size (differentially expressed genes in the
pathway), and x-coordinate recall (overlap size divided by the total number of genes in the pathway).
iScience 23, 100785, January 24, 2020 7
Gene ID NCBI
RefSeq
lncRNA Expression in DAVI Expression
in JCE







100689050 NR_045124.1 Adapt15 3068 D12 vs D4, 1.80
3080 D12 vs D4, 3.36
3478 D12 vs D4, 5.21
D12 3068 vs 3478, 2.86
D12 3077 vs 3478, 3.36
D12 3080 vs 3478, 1.88






103158913 XR_478428.1 GAS5 3077 D12 vs D4, 1.98
3478 D12 vs D4, 2.47





0.023 NR_002840.2 1 3 1065 snoRNA host
gene tumor
suppressor
103158906 XR_478426.2 PVT1 3068 D12 vs D4, 1.91
3080 D12 vs D4, 3.59
D4 3077 vs 3478, 2.70
D12 3068 vs 3478, 2.71
D12 3077 vs 3478, 3.59













Table 2. Three Identified Potential lncRNAs Targets for Cell Engineering with an Established Function in the Literature and an Ortholog in Mouse
From left to right, the table indicates the GeneID and NCBI RefSeq accessions, the gene name, the statistically significant fold-change in DAVI and JCE datasets, the RFAM secondary structure family and
accession numbers, the coding probability measured in the Coding Potential Calculator 2 (CPC2) (Kang et al., 2017), the mouse homologue transcript with the corresponding E-value obtained using the disc


























differentially regulated. Taken together, literature evidence and the presented data suggest the accumu-
lation of GAS5 may be the result of slower translation efficiency caused by an attenuation of mTOR
signaling in the later stages of culture, when recombinant protein production is at its peak, leading to lower
productivity.
A third well-characterized lncRNA in other organisms that was identified in our system as differentially regu-
lated was plasmacytoma variant translocation 1 (PVT1). PVT1 is a non-coding oncogene related to poor prog-
nosis in different cancer types (Zhu et al., 2017) with reports of competing endogenous RNA (ceRNA) activity
on the miR200 microRNA family and direct interaction with the Myc oncogene (Colombo et al., 2015; Tseng
and Bagchi, 2015; Tseng et al., 2014). PVT1 has also been found to induce PI3K/AKT cascade activation, a
pathway we found consistently dysregulated in KEGG functional enrichment (Sun et al., 2019). In a previous
work (Vito and Smales, 2018), we identified the uncharacterized gene LOC103158906 as an ortholog of mouse
PVT1 in CHO using BLAST and secondary structure prediction in RFAM. PVT1 is annotated in C_griseus_v1.0
as LOC103162981, giving the same BLAST alignment scores and RFAM.Myc proto-oncogene protein is pre-
dicted to be encoded in CHO as LOC100758352, containing Myc amino-terminal region (Myc_N), helix-loop-
helix DNA-binding domain (HLH), and a Myc leucine zipper domain (Myc-LZ). PVT1 expression was upregu-
lated by more than two-fold at Day 12 in every producer compared with the null pool in the DAVI dataset
and at both Day 4 and Day 7 in the JCE dataset for 3068 compared with 3936, the clone with the highest yield
and the pool with the lowest yield, respectively. We then investigated the connection between PVT1 andMyc
by measuring the ratio of expression in the JCE and DAVI datasets for 3068 and 3080 (Figure 5). Although
seed-train samples showed an initial discrepancy between the two clones, the ratio was comparable among
later time points, a predominant Myc expression at Day 7, when the exponential growth phase is sustained by
active proliferation, while PVT1 expression increases substantially at Day 12 (Figure 5). When assessing the
direct interaction probability of CHO PVT1 (XR_478426.2) andMyc (XP_003516054.2) using lncPro and RPISeq
prediction tools, the output suggested a strong likelihood of interaction, scoring 85.1 and 0.9, respectively (Lu
et al., 2013;Muppirala et al., 2011). Collectively these data suggest a relationship between PVT1,Myc, andpro-
liferation in the early stages of culture whenMyc activity is preponderant and a strong overexpression of PVT1
toward Day 12 that may promote IgG production.
Comparison of Data Presented Here with Existing Datasets
A recent meta-analysis publication compared transcriptomics studies in CHO cells, commenting on the dif-
ficulty in comparing these datasets but also identifying themost recurrent genes identified as related toQp
and growth (Tamosaitis and Smales, 2018). Here, we find that a number of the coding genes in this study
were regulated in agreement with this meta-analysis study (Data S3). The gene ranking first in the list of the
meta-analysis was Cd36, a multifunctional glycoprotein acting as receptor for a broad range of ligands of
proteinaceous or lipidic nature (Yang et al., 2017), which was consistently downregulated in producers
compared with the null pool in the DAVI dataset at both time points (Table 3). In addition, Cd36 was
strongly downregulated in 3068 and 3080, the cell lines with the highest Qp in the JCE dataset, compared
with 3936 and 4384 at both Day 4 and Day 7. Heat shock protein family A member 8 (Hspa8), a molecular
Figure 5. Analysis of the Expression over Time of the Two Functionally Related Genes (mRNA/lncRNA) mTOR-
GAS5 and Myc-PVT1
Relative ratio or proportion of expression over time for the two functionally related genes (mRNA/lncRNA), mTOR-GAS5
(on the left) and Myc-PVT1 (on the right). These data were obtained by integrating the DAVI and JCE datasets for the 3080
(in red) and 3068 (in blue) clones. To allow the integration of the two different datasets, the proportion is reported as the
gene expression ratio for the indicated gene couple at the specific time point.
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Dataset Gene Time Point Cell Line FC padj
DAVI Cd36 D12 vs D4 3080 4.31 8.03 3 1015
D4 3068 vs 3478 2.55 2.29 3 103
D4 3077 vs 3478 3.40 2.77 3 108
D4 3080 vs 3068 2.53 5.53 3 103
D4 3080 vs 3478 6.45 2.16 3 1025
D12 3068 vs 3478 4.14 1.49 3 1013
D12 3077 vs 3478 4.31 8.03 3 1015
D12 3080 vs 3478 6.63 1.35 3 1027
JCE Cd36 D4 3936 vs 3080 5.75 4.62 3 107
D4 4384 vs 3068 4.28 6.20 3 106
D4 4384 vs 3080 11.33 6.85 3 1018
D7 3936 vs 3080 6.16 5.89 3 1010
D7 4384 vs 3068 5.10 3.64 3 108
D7 4384 vs 3080 13.44 6.76 3 1026
DAVI Serpinh1 D12 vs D4 3068 1.83 6.03 3 103
D12 vs D4 3077 1.85 3.09 3 103
D12 vs D4 3080 2.00 9.49 3 106
D12 3068 vs 3478 1.90 6.06 3 104
D12 3077 vs 3478 2.00 9.49 3 106
D12 3080 vs 3478 2.08 5.98 3 107
JCE Serpinh1 D7 3936 vs 3080 2.03 5.96 3 102
DAVI Vim D12 vs D4 3068 2.47 4.67 3 107
D12 vs D4 3077 3.40 1.30 3 1018
D12 vs D4 3080 3.28 6.80 3 1017
D12 3068 vs 3478 2.64 9.90 3 109
D12 3077 vs 3478 3.28 6.80 3 1017
D12 3080 vs 3478 2.61 3.25 3 108
JCE Vim D4 4384 vs 3080 2.14 1.19 3 102
D7 3936 vs 3080 2.73 9.30 3 107
D7 4384 vs 3080 2.19 7.49 3 103
DAVI Hspa8 D12 vs D4 3068 3.93 9.49 3 1045
D12 vs D4 3077 3.41 2.54 3 1032
D12 vs D4 3080 3.90 1.23 3 1043
D12 3068 vs 3478 3.59 5.35 3 1036
D12 3077 vs 3478 3.90 1.23 3 1043
D12 3080 vs 3478 2.18 1.41 3 106
Table 3. Top Four Differentially Expressed Genes Based on Occurrence in the DAVI and JCE Datasets Based on a Recent Meta-Analysis Comparison
of Transcriptomics Studies in CHO Cells Linked to Qp and Growth
From left to right, the table indicates the dataset, the gene, the time point, and cell line used in the comparison, the fold-change, and the adjusted p value
(Tamosaitis and Smales, 2018).
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chaperone implicated in the protein quality control system and protection of the proteome from stress
(Stricher et al., 2013), was downregulated at Day 12 against Day 4 in the DAVI dataset among every pro-
ducer cell line and when compared with the null 3478 cell line at Day 12 (Table 3). An identical pattern
of downregulation was shown by both Serpinh1, a collagen-specific molecular chaperone localized to
the ER (Ito and Nagata, 2017), and vimentin (Vim), a type III intermediate filament protein responsible
for maintaining cell shape and stabilizing cytoskeletal interactions (Musaelyan et al., 2018). Overall,
Cd36, Hspa8, Serpinh1, and Vim were consistently downregulated in cell lines with higher Qp in our data-
sets in agreement with previous transcriptomics studies summarized in the meta-analysis (Tamosaitis and
Smales, 2018).
Conclusion
In this work we present and make available to the community two RNA-Seq-derived transcriptomic data-
sets that comprehensively detail coding and non-coding transcript expression analysis of five IgG1-produc-
ing CHO cell lines and one null pool at different time points cultivated under fed-batch conditions in an
ambr15 system. In particular, we use RNA-Seq to confirm the expression of lncRNAs in CHO cells and
identify those whose expression is differentially regulated throughout fed-batch culture and between
cell lines with different characteristics. The different time points for sample collection throughout culture
and Qp of cell lines were clearly reflected in the PCA clustering of the transcript expression analysis and
in the numbers of differentially expressed genes for the DAVI dataset. In addition, feeding was shown to
be a significant source of variability even at early stage of culture, as shown by the comparison of seed train
flask data used to inoculate the fed-batch process. These data show that there is a significant change in
gene expression after only four days of culture among the same clone when the cells are still rapidly
growing and dividing and before the major phase of production of the protein of interest. Taking into
account this early transcriptional variability induced by changes in culture conditions, leading to differential
regulation of the genome maintenance pathways, could be beneficial for a more effective cell engineering
and clone selection in industrial settings.
KEGG functional enrichment analysis confirmed a tendency of pathways in the replication and repair
domain to be differentially regulated in response to feeding when the seed train is inoculated in the
fed-batch process and toward Day 12 in particular. The only exception was the clone with the highest
Qp at Day 12, 3080, which interestingly did not show any differentially regulated pathways in the replication
and repair domain. These data suggest that those cell lines that can maintain genome integrity and its
surveillance may be better suited to prolonged culture and recombinant protein productivity. Although
our datasets contained six different cell lines, we wanted to identify coding genes correlated to an increase
in Qp across literature to improve robustness across different systems, leading to the identification of
Cd36, Hspa8, Serpinh1, and Vim as genes negatively correlated with Qp in both our datasets and the
most recent transcriptomics meta-analysis in CHO cells (Tamosaitis and Smales, 2018). Although the
functions of those genes are heterogeneous, the conserved pattern of expression among very different
experimental settings and cell lines suggests conserved roles with detrimental effects on Qp. Knock-out
(KO) or knock-down (KD) strategies on the aforementioned genes with CRISPR or RNA interference could
be implemented to investigate and validate any effects (Lee et al., 2015; Wu, 2009).
In conclusion, although many studies in CHO cells have investigated coding genes, our work aimed to un-
veil the non-coding transcriptome variation, specifically lncRNAs. We identified Adapt15, GAS5, and PVT1
amongmany others as lncRNAs linked to Qp. Although these genes lack an annotation in Chinese hamster
genomes, their effects in model organisms and human diseases are well established (Colombo et al., 2015;
Hollander et al., 1996; Ma et al., 2016). Although Adapt15 was initially identified in hamster and later linked
to ER stress, DNA damage, and cell death, its role in CHO cells has never been further investigated.
Adapt15 upregulation in producing cell lines toward Day 12 of culture suggests an increasing stress on
the ER as the recombinant protein is produced. In addition, we found higher levels of Adapt15 to be corre-
lated to complete dysregulation of the genome maintenance pathways toward the end of culture in the
producing clones. Our results suggest Adapt15 as a target for knock-down with RNAi or knock-out with
CRISPR to alleviate its detrimental effects on productivity and genome integrity. GAS5 transcript accumu-
lation occurs as a result of mTOR signaling repression, suggesting its use as a marker of translation repres-
sion and cell growth arrest in specific cell lines. Our data also suggest a correlation between the expression
of the lncRNA PVT1 and ofMyc; the relationship between the two depends on the stage of fed-batch cul-
ture and is reflected in the differential regulation of the PI3K/AKT pathway. When compared with an
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existent public database of gene expression (Singh et al., 2018), these lncRNAs are constitutively expressed
in different CHO-S, CHOK1, and DG44 cell lines, suggesting a conserved functional role that could be ex-
ploited for cell engineering. Although lncRNAs investigation presents specific challenges in CHO due to
the almost complete lack of annotation in the genome, our workflow allowed the identification, among
many, of three strong candidates for cell engineering based on literature, structural predictions, transcrip-
tional expression, and association with coding genes and pathways. Although we were able to propose
functional mechanisms of action using secondary structure and RNA-protein interaction predictions,
focused experimental studies on single transcripts will be required to assess their effects in mammalian
cell factories.
Limitations of the Study
Although we have confirmed the expression of lncRNAs in CHO cells in this study by RNA-seq and qPCR
and shown that the expression of some of these correlates with either cell growth or recombinant protein
productivity, the conclusions around the potential impact of changes in the expression of specific lncRNAs
that relate to productivity or growth across the different CGO cell lines are, at this stage, based upon
correlation analysis only. Such correlation analysis does not imply cause or effect but merrily identifies these
lncRNAs as potentially of interest. In order to determine any definitive link between the expression of
specific lncRNAs and cell growth or productivity, it would be necessary to show experimentally that
manipulation of the identified lncRNAs with expression profiles correlating with these phenotypes
impacted the expected phenotype (growth or productivity) by, for example, knockdown/out or over-
expression studies.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
DATA AND CODE AVAILABILITY
The accession number for the data reported in this paper is Gene Expression Omnibus (GEO) accession
number GEO: GSE140671. The direct link to the data is www.ncbi.nlm.nih.gov/projects/geo/query/acc.
cgi?acc=GSE140671.
The complete RNA-Seq dataset is thus provided as a reference for the community to investigate RNAseq
data from CHO cells (see GEO accession number GEO: GSE140671 and Data S1).
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Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2019.100785.
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Figure S1. Ammonia, glutamine and glutamate concentrations over time for the DAVI dataset (panel A) and the JCE 
dataset (panel B). Data are represented as mean +/- SEM, Related to Figure 1. 
Figure S2. Enriched KEGG pathways based on differentially expressed genes for each comparison between different cell 
lines at the same time point  in the DAVI dataset. Each dot represents a pathway, with color shade representing the p-
value, size proportional  to the overlap size (differentially expressed genes in the pathway) and x-coordinate recall (overlap 
size divided by the total number of genes in the pathway), Related to Figure 4. 
Figure S3. Enriched KEGG pathways based on differentially expressed genes for each comparison among different cell lines 
at day 4 and day 7 in the JCE dataset. Each dot represents a pathway, with color shade representing the p-value, size 
proportional  to the overlap size (differentially expressed genes in the pathway) and x-coordinate recall (overlap size 
divided by the total number of genes in the pathway), Related to Figure 4. 
Figure S4. Enriched KEGG pathways based on differentially expressed genes for each comparison among the same cell line 
at day 4 against seed train culture in the JCE dataset. Each dot represents a pathway, with color shade representing the p-
value, size proportional  to the overlap size (differentially expressed genes in the pathway) and x-coordinate recall (overlap 
size divided by the total number of genes in the pathway), Related to Figure 4. 
Figure S5. Top 30 differentially expressed genes among the replication and repair domain in the DAVI dataset (A) and JCE 





Figure S6. PVT1 and Myc expression in the JCE (top) and DAVI (bottom) datasets, Related to Figure 5. 
Table S1. The table shows the number of differentially expressed genes with adj p-value < 
0.10 for each comparison among the DAVI and JCE datasets, with the percentage of ncRNAs 
genes, Related to Figure 3. 
Comparison DE Genes Dataset ncRNAs [%] 
3068 v 3478 Day 4 371 DAVI 32.1 
3077 v 3478 Day 4 509 DAVI 27.9 
3080 v 3478 Day 4 491 DAVI 26.3 
3080 v 3068 Day 4 570 DAVI 30.2 
3077 v 3068 Day 4 223 DAVI 25.6 
3077 v 3080 Day 4 604 DAVI 30.0 
3068 v 3478 Day 12 1653 DAVI 14.6 
3077 v 3478 Day 12 2255 DAVI 15.4 
3080 v 3478 Day 12 997 DAVI 19.0 
3080 v 3068 Day 12 813 DAVI 25.7 
3077 v 3068 Day 12 280 DAVI 22.1 
3077 v 3080 Day 12 883 DAVI 26.5 
3478 Day 12 v Day 4 4464 DAVI 13.0 
3068 Day 12 v Day 4 2294 DAVI 16.3 
3077 Day 12 v Day 4 2538 DAVI 14.5 
3080 Day 12 v Day 4 2255 DAVI 15.4 
3068 Day 7 v Day 4 417 JCE 8.4 
3080 Day 7 v Day 4 516 JCE 9.1 
3936 Day 7 v Day 4 615 JCE 8.6 
4384 Day 7 v Day 4 181 JCE 8.3 
3068 v 3080 Day 4 301 JCE 20.3 
3068 v 3936 Day 4 170 JCE 19.4 
3936 v 3080 Day 4 316 JCE 17.7 
4384 v 3068 Day 4 701 JCE 10.6 
4384 v 3080 Day 4 1015 JCE 12.6 
4384 v 3936 Day 4 472 JCE 13.3 
3068 v 3080 Day 7 220 JCE 20.9 
3068 v 3936 Day 7 152 JCE 21.1 
3936 v 3080 Day 7 228 JCE 14.9 
4384 v 3068 Day 7 489 JCE 12.1 
4384 v 3080 Day 7 525 JCE 13.5 
4384 v 3936 Day 7 314 JCE 16.9 
3936 FB Day 4 v ST 140 JCE 15.7 
4384 FB Day 4 v ST 306 JCE 9.8 
3080 FB Day 4 v ST 307 JCE 15.6 




Cell culture Four Symphogen in‐house mAb CHO cell clones (designated 3068, 3077, 3080, 4384 
producing the same IgG subtype) and two cell pools, of which one (3936) was IgG1‐producing and the 
other (3478) was a null-producer, were used in this study. All were generated from a modified 
dihydrofolate reductase‐deficient (DHFR‐) CHO DG44 host cell line (Urlaub, Käs, Carothers, & Chasin, 
1983) through transfection with a vector containing the DHFR gene and the genes for the antibody 
heavy (HC) and light chains (LC) and methotrexate (MTX) mediated stable selection . Clones were 
isolated by fluorescence activated cell sorting (FACS). Cells were routinely maintained and expanded 
in PowerCHO-2 CD (Lonza) as basal media in shake flasks with shaking at 190-200 rpm in a 37°C 
humidified culture incubator supplied with 5% CO2.  
For upstream experiments to generate samples for analysis, cells were inoculated at a starting 
concentration of either 0.4x 106 viable cells/ml (DAVI experiments) or 0.6 x 106 viable cells/ml (JCE 
experiments), in a total culture volume of 13 ml. The ambr15 micro bioreactor by Sartorius 
(Goettingen, Germany) was used to run fed-batch culture experiments for either 12 (DAVI) or 14 days 
(JCE). For feeding of cultures, HyClone Cell Boost 6 Supplement (GE Healthcare Bio-Sciences AB, 
Uppsala, Sweden) + 8% FunctionMAX™ TiterEnhancer (ThermoFisher Scientific, Massachusetts, 
United States) was used with a feeding regime of every 2nd or 3rd day for JCE experiments or daily from 
the 2nd day of culture for DAVI experiments. Culture viability and viable cell concentration (VCD) was 
measured using a Vi‐CELL XR (Beckman Coulter, Brea, CA) instrument. For JCE experiments, glucose, 
glutamine, lactate, ammonium, glutamate, pH, and osmolality were measured using a Bioprofile 
100plus (Nova BioMedical, Waltham, WA) instrument while IgG titer was determined by biolayer 
interferometry using an Octet QK384 instrument equipped with Protein G biosensors (ForteBio, Menlo 
Park, CA). For DAVI experiments, a Cedex Bio HT analyser (Roche, Basel, Switzerland) was used for all 
measurements. 
Sampling from Cell Cultures and Subsequent RNA Extraction For seed train samples, cells were 
harvested 48 hours after adjusting their VCD to 0.3x106 viable cells/ml, when a steady doubling time 
and high culture viability were maintained. Cell suspensions from each seed-train in the JCE dataset 
were added to 15 ml Falcon tubes and centrifuged at 1000 rpm for 4 minutes, followed by Direct-zol 
RNA extraction (Zymo Research, California, USA) following the manufacturer’s instructions. For 
samples taken from the fed-batch cultures, 1 x 107 viable cells were taken before feeding from each 
biological replicate ambr15™ bioreactor after 96 h of culture time (day 4, both DAVI and JCE 
experiments) and after either 168 h (day 7, JCE experiment) or 288 h (day 12, DAVI experiment) of 
culture. Cells were lysed using TRI-Reagent (Sigma-Aldrich, Missouri, USA) followed by extraction of 
total RNA using a Direct-zol RNA Kit (Zymo Research) and in-column DNAse treated. The RNA 
quantity/quality was determined using a NanoDrop instrument (ThermoFisher Scientific) and RNA 
6000 Pico Kit (Agilent, California, USA). 
RNA Seq and Data analysis For DAVI experiments: the RNA was sent to the Oxford Genomics Centre 
(Oxford, UK) where the Ribo-Zero ribosomal RNA (rRNA) removal kit (Illumina, California, USA) was 
used to remove rRNAs followed by sequencing on an HiSeq4000 by Illumina. The fastq files were 
initially checked for quality using FastQC, sorted using samtools, deduplicated using Picard 
MarkDuplicates then aligned with HISAT2 to the CriGri_1.0 reference genome. The gene counts were 
calculated using featureCounts, then the differential expression analysis was undertaken with the 
R/Bioconductor package DESeq2 (Love, Huber, & Anders, 2014).  
For JCE experiments: samples were sequenced at Genotypic (Bengaluru, India). The fastq files were 
trimmed using Trim_Galore! and aligned to GCF_000419365.1 with STAR. The gene counts were 
calculated using featureCounts, then the differential expression analysis was conducted with the R 
package DESeq2 (Love et al., 2014) as described for the DAVI experiments. Genes with a fold change 
(FC) > 1.50 and Benjamini-Hochberg adjusted p-value <0.10 in both datasets were selected for GO and 
KEGG enrichment using the Bioconductor package gProfileR (Data S1). 
RT-qPCR Validation of Differentially Expressed genes Primers for RT-qPCR experiments were 
designed using Primer-BLAST and synthetized by Integrated DNA Technologies (Illinois, USA). Primers 
used during this study are described in Data S2. RT-qPCR reactions were conducted using a 
Mastercycler EP Realplex instrument (Eppendorf, Hamburg, Germany) using the PrecisionPLUS 
Onestep qRT-PCR Master Mix kit by Primer Design (Southampton, UK). The specificity of amplification 
was checked by the generation of Tm curves and by analysis of the reaction products using 2% agarose 
gel electrophoresis to confirm the presence of a single amplicon of the expected size. The results were 
analysed applying the standard ΔCt method and normalized to -actin and B2M housekeeping genes 
expression. 
 
 
